About Shenzhen Shenyan Biotechnology
Shenzhen Shenyan Biotechnology is a company based in Shenzhen (China) founded in 2014 by Xue Bofu. Shenzhen Shenyan Biotechnology has raised $56.66 million across 2 funding rounds from investors including Tasly, Eight Roads Ventures and Yuexiu Industrial Fund. Shenzhen Shenyan Biotechnology operates in a competitive market with competitors including Multiply Labs, ThermoGenesis, Cytera, Cellular Origins and Guangdong Bogong Medical Technology, among others.
- Headquarter Shenzhen, China
- Founders Xue Bofu
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$56.66 M (USD)
in 2 rounds
-
Latest Funding Round
$41.71 M (USD), Series B
Feb 20, 2024
-
Investors
Tasly
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Shenzhen Shenyan Biotechnology
Shenzhen Shenyan Biotechnology has successfully raised a total of $56.66M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $41.71 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Shenzhen Shenyan Biotechnology
Shenzhen Shenyan Biotechnology has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Tasly, Eight Roads Ventures and Yuexiu Industrial Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
A leading platform for venture capital and equity investment is operated.
|
Locked | Locked | Locked |
Investor details for Shenzhen Shenyan Biotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Shenzhen Shenyan Biotechnology
Investment portfolio details for Shenzhen Shenyan Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Shenzhen Shenyan Biotechnology
Detailed financials for Shenzhen Shenyan Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Shenzhen Shenyan Biotechnology Comparisons
Peer comparison for Shenzhen Shenyan Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Shenzhen Shenyan Biotechnology
Shenzhen Shenyan Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multiply Labs, ThermoGenesis, Cytera, Cellular Origins and Guangdong Bogong Medical Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision medicines are manufactured via robotic systems for cell therapies.
|
|
| Locked | Locked | Locked |
Automated technologies for cell-based therapeutics and bio-processing are developed.
|
|
| Locked | Locked | Locked |
Automated cell culture devices using T-flasks and incubators are developed.
|
|
| Locked | Locked | Locked |
Automates cell therapy manufacturing through partnerships and robotics integration.
|
|
| Locked | Locked | Locked |
Robotic solutions for life science research are developed.
|
Detailed competitors of Shenzhen Shenyan Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Shenzhen Shenyan Biotechnology
Complete news archive for Shenzhen Shenyan Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shenzhen Shenyan Biotechnology
Shenzhen Shenyan Biotechnology was founded in 2014 and raised its 1st funding round 8 years after it was founded.
Shenzhen Shenyan Biotechnology is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
Ma Mo is the current CEO of Shenzhen Shenyan Biotechnology.
Shenzhen Shenyan Biotechnology is a funded company, having raised a total of $56.66M across 2 funding rounds to date.
Shenzhen Shenyan Biotechnology was established in 2014 in Shenzhen, China, within the biotechnology sector. Automated systems for cell processing are created to support cell and gene therapies. The CellSep PRO system is utilized for customized cell preparation through gradient centrifugation. The EuLV system is also employed, serving as a stable cell line-based method for lentiviral vector production. Operations focus on these technologies to aid therapeutic applications.
Shenzhen Shenyan Biotechnology's top competitors include Multiply Labs, Celltrio and ThermoGenesis.
Shenzhen Shenyan Biotechnology has 5 investors. Key investors include Tasly, Eight Roads Ventures, Yuexiu Industrial Fund, Dachen Caizhi Venture Capital Management, and ABC Capital.